Typhoid fever vaccines provide protection against typhoid fever caused by Salmonella Typhi bacteria. The market has witnessed increased demand for typhoid fever vaccines owing to the increasing occurrence of typhoid cases worldwide. Typhoid fever is widely prevalent in parts of Africa, Asia, and Latin America, with children being at the highest risk of contracting the disease. The global Typhoid Fever Vaccines Market is estimated to be valued at US$ 454.2 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for effective vaccines is one of the major trends being witnessed in the typhoid fever vaccines market. The widespread prevalence of typhoid fever across developing parts of the world has boosted research efforts focused on developing improved vaccines. Traditionally, typhoid vaccines had lower efficacy and required multiple doses for protection. However, new single-dose vaccines such as Bharat Biotech’s Typbar-TCV vaccine have demonstrated higher levels of protection against the disease. Such advancements are expected to provide a boost to vaccine usage rates globally. Additionally, successful awareness drives by public health organizations regarding the importance of vaccination against typhoid fever have also contributed to the growing demand for these vaccines over the recent past.
The global typhoid fever vaccines market share is segmented based on vaccine type, end use and distribution channel. By vaccine type, the Vi capsular polysaccharide vaccine sub segment dominates the market as it provides strong immunity against typhoid fever. It induces antibody responses specific to the Vi capsular polysaccharide that coats Salmonella Typhi and provides Type-specific protection.
The global typhoid fever vaccines market is expected to witness high growth during the forecast period of 2024 to 2031.
Regional analysis - Europe is currently the fastest growing region in the typhoid fever vaccines market. This is due to rising government initiatives to vaccinate people against typhoid fever in countries like the UK.
Key players operating in the typhoid fever vaccines market are Linde Plc, Air Liquide, Engie, Uniper Se, Air Products Inc, Clean Hydrogen System, Cummins Inc., Toshiba Energy Systems & Solutions Corporation, Nel Asa, and Sgh2 Energy.
Get more insights on this topic: https://www.ukwebwire.com/typhoid-fever-vaccines-market-is-driven-by-rising-awareness-about-typhoid-prevention/